Shuttle Pharmaceuticals (SHPH) Short Interest Ratio & Short Volume $0.18 -0.01 (-3.87%) Closing price 04:00 PM EasternExtended Trading$0.18 0.00 (-1.06%) As of 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Shuttle Pharmaceuticals Short Interest DataShuttle Pharmaceuticals (SHPH) has a short interest of 136,100 shares, representing 4.07% of the float (the number of shares available for trading by the public). This marks a -80.86% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.56 million shares to cover all short positions.Current Short Interest136,100 sharesPrevious Short Interest710,900 sharesChange Vs. Previous Month-80.86%Dollar Volume Sold Short$36,393.14Short Interest Ratio0.0 Days to CoverLast Record DateApril 30, 2025Outstanding Shares6,258,000 sharesFloat Size3,340,000 sharesShort Percent of Float4.07%Today's Trading Volume1,411,640 sharesAverage Trading Volume1,562,017 sharesToday's Volume Vs. Average90% Short Selling Shuttle Pharmaceuticals? Sign up to receive the latest short interest report for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSHPH Short Interest Over TimeSHPH Days to Cover Over TimeSHPH Percentage of Float Shorted Over Time Shuttle Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025136,100 shares $36,393.14 -80.9%4.1%0 $0.27 4/15/2025710,900 shares $185,544.90 +961.0%21.3%1.1 $0.26 3/31/202567,000 shares $26,063.00 +73.6%2.0%0.3 $0.39 3/15/202538,600 shares $14,282.00 -8.3%0.9%0.3 $0.37 2/28/202542,100 shares $25,630.48 +63.8%1.3%0.4 $0.61 2/15/202525,700 shares $17,982.29 +176.3%1.1%0.3 $0.70 1/31/20259,300 shares $7,002.90 +3.3%0.4%0.1 $0.75 1/15/20259,000 shares $7,569.00 -73.5%0.3%0 $0.84 12/31/202433,900 shares $29,120.10 +1,312.5%1.2%0 $0.86 12/15/20242,400 shares $1,643.28 -95.8%0.1%0 $0.68 Get the Latest News and Ratings for SHPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/202456,900 shares $48,251.20 -3.4%2.3%0.1 $0.85 11/15/202458,900 shares $58,723.30 -91.6%2.6%0 $1.00 10/31/2024702,600 shares $1.31 million +1,984.9%34.8%0.5 $1.87 10/15/202433,700 shares $37,407.00 -18.0%1.7%0.1 $1.11 9/30/202441,100 shares $54,663.00 -52.1%2.0%0.1 $1.33 9/15/202485,800 shares $145,860.00 +909.4%6.9%0.2 $1.70 8/31/20248,500 shares $16,405.00 -59.1%0.7%0 $1.93 8/15/202420,800 shares $43,472.00 -86.7%1.8%0.5 $2.09 7/31/2024156,500 shares $62,584.35 +112.1%1.7%0.5 $0.40 7/15/202473,800 shares $31,143.60 +138.1%0.8%0.3 $0.42 6/30/202431,000 shares $12,393.77 +46.2%0.3%0.5 $0.40 6/15/202421,200 shares $9,164.76 -43.9%0.2%0.4 $0.43 5/31/202437,800 shares $20,071.80 -7.4%0.4%0.6 $0.53 5/15/202440,800 shares $16,483.20 -41.6%0.4%1 $0.40 4/30/202469,800 shares $28,415.58 -4.4%0.7%1.4 $0.41 4/15/202473,000 shares $29,915.40 +11.3%0.8%1.3 $0.41 3/31/202465,600 shares $26,633.60 -0.5%0.7%0.5 $0.41 3/15/202465,900 shares $30,314.00 +28.2%0.8%0.4 $0.46 2/29/202451,400 shares $20,123.10 -41.4%0.6%0.3 $0.39 2/15/202487,700 shares $32,212.21 -35.3%1.0%0.6 $0.37 1/31/2024135,500 shares $54,105.15 +61.3%1.6%0.9 $0.40 1/15/202484,000 shares $38,220.00 -25.3%1.0%0.5 $0.46 12/31/2023112,400 shares $51,142.00 +497.9%1.3%1 $0.46 12/15/202318,800 shares $8,988.28 -37.3%0.2%0.2 $0.48 11/30/202330,000 shares $14,997.00 -30.1%0.3%0.3 $0.50 11/15/202342,900 shares $21,235.50 -36.3%0.5%0.3 $0.50 10/31/202367,300 shares $31,294.50 -35.0%0.8%0.5 $0.47 10/15/2023103,600 shares $64,232.00 +5.4%1.2%0.7 $0.62 9/30/202398,300 shares $59,963.00 +15.4%1.3%0.6 $0.61 9/15/202385,200 shares $60,747.60 -37.6%1.1%0.5 $0.71Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 8/31/2023136,500 shares $100,996.35 +7.2%1.9%0.7 $0.74 8/15/2023127,300 shares $108,192.27 -23.5%1.8%0.1 $0.85 7/31/2023166,300 shares $149,686.63 +43.2%2.6%0.1 $0.90 7/15/2023116,100 shares $119,583.00 +20.7%1.8%0.1 $1.03 6/30/202396,200 shares $110,630.00 -52.6%1.5%0.1 $1.15 6/15/2023202,900 shares $213,045.00 -65.1%3.5%0.1 $1.05 5/31/2023582,100 shares $646,538.47 +1,008.8%10.1%0.4 $1.11 5/15/202352,500 shares $56,700.00 No Change1.0%0 $1.08 SHPH Short Interest - Frequently Asked Questions What is Shuttle Pharmaceuticals' current short interest? Short interest is the volume of Shuttle Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 136,100 shares of SHPH short. 4.07% of Shuttle Pharmaceuticals' shares are currently sold short. Learn More on Shuttle Pharmaceuticals' current short interest. What is a good short interest percentage for Shuttle Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.07% of Shuttle Pharmaceuticals' floating shares are currently sold short. Is Shuttle Pharmaceuticals' short interest increasing or decreasing? Shuttle Pharmaceuticals saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 136,100 shares, a drop of 80.9% from the previous total of 710,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Shuttle Pharmaceuticals' float size? Shuttle Pharmaceuticals currently has issued a total of 6,258,000 shares. Some of Shuttle Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Shuttle Pharmaceuticals currently has a public float of 3,340,000 shares. How does Shuttle Pharmaceuticals' short interest compare to its competitors? 4.07% of Shuttle Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Shuttle Pharmaceuticals: Sonoma Pharmaceuticals, Inc. (5.09%), Ensysce Biosciences, Inc. (6.09%), Aptorum Group Limited (2.10%), CNS Pharmaceuticals, Inc. (21.57%), Evoke Pharma, Inc. (1.75%), Alaunos Therapeutics, Inc. (3.42%), Dermata Therapeutics, Inc. (5.76%), Jaguar Health, Inc. (20.36%), Onconetix, Inc. (5.69%), Lixte Biotechnology Holdings, Inc. (0.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Shuttle Pharmaceuticals stock? Short selling SHPH is an investing strategy that aims to generate trading profit from Shuttle Pharmaceuticals as its price is falling. SHPH shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Shuttle Pharmaceuticals? A short squeeze for Shuttle Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SHPH, which in turn drives the price of the stock up even further. How often is Shuttle Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SHPH, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies SNOA Short Interest Data ENSC Short Interest Data APM Short Interest Data CNSP Short Interest Data EVOK Short Interest Data TCRT Short Interest Data DRMA Short Interest Data JAGX Short Interest Data ONCO Short Interest Data LIXT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SHPH) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.